GGrantIndex
Sort

85,873 grants matching alzheimers

Molecular, Cellular and Circuit Mechanisms for Age-Related Deficits in Memory-Linking

$2,120,292
Alcino J. Silva · University Of California Los Angeles · RF1 · FY2022 · AG

Alzheimer's Disease Research Center at Columbia Univ.

$2,119,747
Columbia University Health Sciences · P50 · FY2005 · AG

MicroRNA regulation of central nervous system and systemic inflammation in AD

$2,119,511
Suman Jayadev · University Of Washington · RF1 · FY2015 · AG

A novel human 3D neural cell culture system for the characterization of AD genes

$2,119,500
Rudolph Emile Tanzi · Massachusetts General Hospital · RF1 · FY2014 · AG

Dysregulation of Multivesicular Body and Exosome Flux in Alzheimer's Disease

$2,118,687
Zixu Mao · Emory University · RF1 · FY2021 · AG

Michigan Alzheimer's Disease Core Center

$2,118,485
Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2020 · AG

Brooklyn Women's Interagency HIV Study (WIHS) V

$2,117,738
Howard Minkoff · Suny Downstate Medical Center · U01 · FY2015 · AI

Cleveland Alzheimer's Disease Research Center

$2,117,487
James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · P30 · FY2019 · AG

The genetic basis of complex traits: from yeast to humans

$2,117,247
Hunter B Fraser · Stanford University · R35 · FY2025 · GM

Clinical and Biological Studies of Early AD

$2,116,928
Vahram Haroutunian · Icahn School Of Medicine At Mount Sinai · P01 · FY2006 · AG

Person-Reported and Health Care Utilization Outcomes of Home and Community Based Care Recipients With and Without Alzheimer's Disease and its Related Dementias

$2,116,405
Tetyana P. Shippee · University Of Minnesota · RF1 · FY2020 · AG

Presenilin Biology and the Mechanism of Alzheimer's Disease

$2,116,155
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2008 · AG

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$2,115,683
Nigel H. Greig · National Institute On Aging · ZIA · FY2020 · AG

Cleveland Alzheimer's Disease Research Center

$2,115,312
James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · P30 · FY2020 · AG

Administrative Core

$2,115,278
Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG

Trends and Dynamics in Caregiving for Alzheimer’s Disease and Related Dementias: Extending the National Study of Caregiving

$2,115,062
Vicki A. Freedman · University Of Michigan At Ann Arbor · R01 · FY2022 · AG

DementiaBank: An open access language database to understand the progression of dementia

$2,114,910
Brian Macwhinney · Carnegie-Mellon University · RF1 · FY2023 · AG

Examining the Persistence of Neurocognitive Benefits of Exercise

$2,112,851
Kirk I Erickson · Adventhealth Orlando · R01 · FY2024 · AG

Testing Optimal Gene Editor for an Alzheimer's CRISPR therapeutic.

$2,112,826
Subhojit Roy · University Of California, San Diego · UF1 · FY2023 · NS

Fibrillar polymorphs in human brain tissue

$2,112,290
Lee Makowski · Northeastern University · RF1 · FY2023 · AG

Patient and Family Member Reactions to Biomarker-Informed ADRD Diagnoses

$2,112,023
Jennifer Hagerty Lingler · University Of Pittsburgh At Pittsburgh · RF1 · FY2023 · AG

Molecular Basis of Mitochondrial Dysfunction in Neurodegeneration

$2,111,031
Kenneth R Norman · Albany Medical College · RF1 · FY2019 · AG

Screening and Survey Instrument Development Core

$2,110,864
James R Wagner · University Of Michigan At Ann Arbor · U54 · FY2023 · AG

Potassium Channels and Dendritic Function in Hippocampal Pyramidal Neurons

$2,110,664
Dax A Hoffman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

Translational Evaluation of PET Radiotracers

$2,110,573
Robert Innis · National Institute Of Mental Health · ZIA · FY2025 · MH